Trial of Early Aggressive Drug Therapy in Juvenile Idiopathic Arthritis
Status:
Completed
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare two aggressive drug regimens for children with
poly-juvenile idiopathic arthritis (JIA) and extended oligo JIA.
Phase:
Phase 4
Details
Lead Sponsor:
Seattle Children's Hospital
Collaborators:
Amgen National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)